Sponsor content
176 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 0.5 mg semaglutide 1.0 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 0.25 mg semaglutide 0.5 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 2.4 mg semaglutide 3.2 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1 mg semaglutide 2.0 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled syringe.
-
Nov-2025Prescription medicine evaluationActive ingredient: denecimig.
-
Sep-2025Prescription medicine evaluationActive ingredient: Semaglutide.
-
Prescription medicine registrationActive ingredients: Semaglutide.
-
Australian public assessment report (AusPar)AWIQLI (insulin icodec) has been approved for the treatment, in adults, of type 2 diabetes and type 1 diabetes in conjunction with a bolus insulin, where daily basal insulin injections are not suitable.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXPEN insulin degludec 100 U/mL solution for injection multidose cartridge.